Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Episodes

Specialty:

All

Year:

All

EP. 1: Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

January 16th 2017

EP. 2: Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

January 16th 2017

EP. 3: Monitoring Azole Levels in Transplant Patients

January 16th 2017

EP. 4: Morbidity from CMV Infection in Transplant Patients

January 16th 2017

EP. 5: The Need for CMV Prophylaxis in the Transplant Setting

January 16th 2017

EP. 6: Letermovir for CMV Prophylaxis in Transplant Patients

January 16th 2017

EP. 7: Letermovir Phase III Trial

January 16th 2017

Trending on OncLive

CLL Treatment Individualization Prompts Changes in Patient Evaluation and Care

Japan Approves Subcutaneous Pembrolizumab for All Approved Pembrolizumab Indications

FDA Grants Fast Track Designation to LYT-200 in R/R High-Risk MDS

Integrating Bispecific Antibodies Into Frontline Therapy for Newly Diagnosed Multiple Myeloma

NAPISTAR-1-01 Data Support Rapid TUB-040 Development in Biomarker-Unrestricted Ovarian Cancer